• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列环素通过激活过氧化物酶体增殖物激活受体γ来预防小鼠肺癌,且不依赖于膜受体。

Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.

作者信息

Nemenoff Raphael, Meyer Amy M, Hudish Tyler M, Mozer Anthony B, Snee Amy, Narumiya Shuh, Stearman Robert S, Winn Robert A, Weiser-Evans Mary, Geraci Mark W, Keith Robert L

机构信息

Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Health Sciences Center, Denver, CO, USA.

出版信息

Cancer Prev Res (Phila). 2008 Oct;1(5):349-56. doi: 10.1158/1940-6207.CAPR-08-0145.

DOI:10.1158/1940-6207.CAPR-08-0145
PMID:19138979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2680197/
Abstract

Overexpression of prostacyclin synthase (PGIS) decreases lung tumor multiplicity in chemical- and cigarette-smoke-induced murine lung cancer models. Prostacyclin signals through a single G-protein-coupled receptor (IP), which signals through cyclic AMP. To determine the role of this receptor in lung cancer chemoprevention by prostacyclin, PGIS-overexpressing mice were crossed to mice that lack the IP receptor [IP(-/-)]. Carcinogen-induced lung tumor incidence was similar in IP(+/+), IP(+/-), and IP(-/-) mice, and overexpression of PGIS gave equal protection in all three groups, indicating that the protective effects of prostacyclin are not mediated through activation of IP. Because prostacyclin can activate members of the peroxisomal proliferator-activated receptor (PPAR) family of nuclear receptors, we examined the role of PPARgamma in the protection of prostacyclin against lung tumorigenesis. Iloprost, a stable prostacyclin analogue, activated PPARgamma in nontransformed bronchial epithelial cells and in a subset of human non-small-cell lung cancer cell lines. Iloprost-impregnated chow fed to wild-type mice resulted in elevated lung macrophages and decreased lung tumor formation. Transgenic animals with lung-specific PPARgamma overexpression also developed fewer lung tumors. This reduction was not enhanced by administration of supplemental iloprost. These studies indicate that PPARgamma is a critical target for prostacyclin-mediated lung cancer chemoprevention and may also have therapeutic activity.

摘要

在化学物质和香烟烟雾诱导的小鼠肺癌模型中,前列环素合酶(PGIS)的过表达可降低肺肿瘤的多发性。前列环素通过单一的G蛋白偶联受体(IP)发出信号,该受体通过环磷酸腺苷发挥作用。为了确定该受体在前列环素对肺癌化学预防中的作用,将过表达PGIS的小鼠与缺乏IP受体的小鼠[IP(-/-)]进行杂交。致癌物诱导的肺肿瘤发生率在IP(+/+)、IP(+/-)和IP(-/-)小鼠中相似,PGIS的过表达在所有三组中均提供了同等的保护作用,这表明前列环素的保护作用不是通过IP的激活介导的。由于前列环素可激活核受体过氧化物酶体增殖物激活受体(PPAR)家族的成员,我们研究了PPARγ在前列环素预防肺肿瘤发生中的作用。伊洛前列素,一种稳定的前列环素类似物,可在未转化的支气管上皮细胞和一部分人非小细胞肺癌细胞系中激活PPARγ。给野生型小鼠喂食含伊洛前列素的食物会导致肺巨噬细胞增多,肺肿瘤形成减少。肺特异性过表达PPARγ的转基因动物也产生较少的肺肿瘤。补充伊洛前列素并未增强这种减少。这些研究表明,PPARγ是前列环素介导的肺癌化学预防的关键靶点,也可能具有治疗活性。

相似文献

1
Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma.前列环素通过激活过氧化物酶体增殖物激活受体γ来预防小鼠肺癌,且不依赖于膜受体。
Cancer Prev Res (Phila). 2008 Oct;1(5):349-56. doi: 10.1158/1940-6207.CAPR-08-0145.
2
Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention.前列环素和 EMT 通路标志物用于监测肺癌化学预防的反应。
Cancer Prev Res (Phila). 2018 Oct;11(10):643-654. doi: 10.1158/1940-6207.CAPR-18-0052. Epub 2018 Jul 25.
3
Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.平滑肌增殖和前列环素(IP)受体在特发性肺动脉高压中的作用。
Am J Respir Crit Care Med. 2010 Nov 1;182(9):1161-70. doi: 10.1164/rccm.201001-0011OC. Epub 2010 Jul 9.
4
TARGETING THE PROSTACYCLIN/PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA AXIS IN LUNG CANCER CHEMOPREVENTION.靶向前列环素/过氧化物酶体增殖物激活受体γ轴进行肺癌化学预防
Trans Am Clin Climatol Assoc. 2018;129:48-55.
5
The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model.第二代 PGI2 类似物曲前列尼尔未能预防小鼠肺腺癌模型中的肿瘤。
Cancer Prev Res (Phila). 2017 Nov;10(11):671-679. doi: 10.1158/1940-6207.CAPR-17-0050. Epub 2017 Aug 29.
6
Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.伊洛前列素,一种前列环素类似物,通过IP依赖途径下调基质金属蛋白酶-2(MMP-2)来抑制卵巢癌细胞的侵袭。
Prostaglandins Other Lipid Mediat. 2018 Jan;134:47-56. doi: 10.1016/j.prostaglandins.2017.12.002. Epub 2017 Dec 30.
7
Temporal expression and signalling of prostacyclin receptor in the human endometrium across the menstrual cycle.人子宫内膜中前列环素受体在整个月经周期中的时间表达及信号传导
Reproduction. 2004 Jan;127(1):79-86. doi: 10.1530/rep.1.00038.
8
Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.人呼吸道上皮细胞中前列环素的第二种受体的证据,该受体介导对 CXCL9 和 CXCL10 释放的抑制。
Mol Pharmacol. 2011 Mar;79(3):586-95. doi: 10.1124/mol.110.069674. Epub 2010 Dec 20.
9
Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.肺前列环素合酶过表达可化学预防小鼠烟草烟雾诱导的肺癌发生。
Cancer Res. 2004 Aug 15;64(16):5897-904. doi: 10.1158/0008-5472.CAN-04-1070.
10
Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.吉非替尼联合前列环素合酶过表达对小鼠肺癌的化学预防作用。
Lung Cancer. 2010 Oct;70(1):37-42. doi: 10.1016/j.lungcan.2010.01.004. Epub 2010 Jan 29.

引用本文的文献

1
Hydrogel-embedded precision-cut lung slices support ex vivo culture of in vivo-induced premalignant lung lesions.水凝胶包埋的肺组织薄片支持体内诱导的癌前肺病变的体外培养。
Physiol Rep. 2025 Jul;13(13):e70459. doi: 10.14814/phy2.70459.
2
Analysis of nuclear receptor expression in head and neck cancer.头颈部癌症中核受体表达的分析。
Cancer Genet. 2025 Jan;290-291:61-71. doi: 10.1016/j.cancergen.2024.12.003. Epub 2024 Dec 26.
3
Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.

本文引用的文献

1
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.功能失调的前列环素受体突变导致心血管疾病加速:对环氧合酶-2抑制的潜在影响
Circ Res. 2008 Apr 25;102(8):986-93. doi: 10.1161/CIRCRESAHA.107.165936. Epub 2008 Mar 6.
2
Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.过氧化物酶体增殖物激活受体γ在非小细胞肺癌细胞中的抗肿瘤作用是通过抑制核因子κB来抑制环氧化酶-2介导的。
Mol Pharmacol. 2008 Mar;73(3):709-17. doi: 10.1124/mol.107.042002. Epub 2007 Nov 30.
3
吸入伊洛前列素预防肺癌的 Ib 期试验及预测和反应生物标志物评估
Front Oncol. 2023 Aug 30;13:1204726. doi: 10.3389/fonc.2023.1204726. eCollection 2023.
4
Precision Cut Lung Slices as a Preclinical Model for Non-Small Cell Lung Cancer Chemoprevention.精准切取肺切片作为非小细胞肺癌化学预防的临床前模型。
Cancer Prev Res (Phila). 2023 May 1;16(5):247-258. doi: 10.1158/1940-6207.CAPR-23-0004.
5
Iloprost requires the Frizzled-9 receptor to prevent lung cancer.伊洛前列素需要卷曲蛋白9受体来预防肺癌。
iScience. 2022 May 23;25(6):104442. doi: 10.1016/j.isci.2022.104442. eCollection 2022 Jun 17.
6
miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention.miR-520a-5p 调控卷曲蛋白 9 的表达并介导香烟烟雾和伊洛前列素化学预防的作用。
Sci Rep. 2022 Feb 11;12(1):2388. doi: 10.1038/s41598-022-06292-7.
7
Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.前列腺素途径:癌症预防和治疗的机会。
Cancer Res. 2022 Mar 15;82(6):949-965. doi: 10.1158/0008-5472.CAN-21-2297.
8
Cancer chemoprevention through Frizzled receptors and EMT.通过卷曲受体和上皮-间质转化进行癌症化学预防。
Discov Oncol. 2021;12(1):32. doi: 10.1007/s12672-021-00429-2. Epub 2021 Sep 9.
9
Intranasal Iloprost Prevents Tumors in a Murine Lung Carcinogenesis Model.经鼻给予伊洛前列素可预防小鼠肺癌发生模型中的肿瘤。
Cancer Prev Res (Phila). 2022 Jan;15(1):11-16. doi: 10.1158/1940-6207.CAPR-21-0086. Epub 2021 Sep 23.
10
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).癌症和心力衰竭的常见机制途径。代表欧洲心脏病学会(ESC)心力衰竭协会(HFA)转化研究委员会的科学路线图。
Eur J Heart Fail. 2020 Dec;22(12):2272-2289. doi: 10.1002/ejhf.2029. Epub 2020 Nov 12.
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.
罗格列酮心血管结局评估——一项中期分析。
N Engl J Med. 2007 Jul 5;357(1):28-38. doi: 10.1056/NEJMoa073394. Epub 2007 Jun 5.
4
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
5
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.噻唑烷二酮类药物与糖尿病患者患肺癌、前列腺癌和结肠癌的风险
J Clin Oncol. 2007 Apr 20;25(12):1476-81. doi: 10.1200/JCO.2006.07.2777.
6
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.吡格列酮和罗格列酮通过上调15-羟基前列腺素脱氢酶来降低非小细胞肺癌细胞中前列腺素E2的水平。
Mol Pharmacol. 2007 Jun;71(6):1715-20. doi: 10.1124/mol.106.033357. Epub 2007 Apr 5.
7
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
8
Distinct role of macrophages in different tumor microenvironments.巨噬细胞在不同肿瘤微环境中的独特作用。
Cancer Res. 2006 Jan 15;66(2):605-12. doi: 10.1158/0008-5472.CAN-05-4005.
9
Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.巨噬细胞和肥大细胞对肿瘤细胞岛的浸润赋予非小细胞肺癌显著的生存优势。
J Clin Oncol. 2005 Dec 10;23(35):8959-67. doi: 10.1200/JCO.2005.01.4910. Epub 2005 Oct 11.
10
PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.过氧化物酶体增殖物激活受体γ(PPAR-γ)激活通过阻断非小细胞肺癌中ELR+CXC趋化因子的产生来抑制血管生成。
Neoplasia. 2005 Mar;7(3):294-301. doi: 10.1593/neo.04601.